SCYX =MCap $60 M / Cash $35 M / NDA submission for first Drug within 4 months ($400 Million Commercial Opporunity ) / Another 3 Drugs in Phase 3 trials / Potential Covid 19 Gem = Brutally underpriced low float gem a potential 10 Bagger here guys .....GLTA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.